Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases

scientific article published on 21 January 2014

Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2014PLoSO...986543Z
P356DOI10.1371/JOURNAL.PONE.0086543
P932PMC publication ID3897724
P698PubMed publication ID24466143
P5875ResearchGate publication ID259920372

P50authorYunshi ZhongQ114315420
P2093author name stringQi Lin
Li Ren
Jianmin Xu
Dexiang Zhu
Tianshu Liu
Ye Wei
Qinghai Ye
Xinyu Qin
Lechi Ye
P2860cites workPredictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983).Q53388486
Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter?Q82418582
Resectable colorectal liver metastases: optimal sequencing of chemotherapyQ83509575
Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?Q84766645
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialQ24647888
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.Q33330997
Surgery for colorectal liver metastases.Q33834452
Trends in long-term survival following liver resection for hepatic colorectal metastasesQ34523502
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastasesQ36464103
Hepatectomy for resectable colorectal cancer metastases--indicators of prognosis, definition of resectability, techniques and outcomesQ36867825
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapyQ37287048
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panelQ37372198
The role of preoperative chemotherapy in patients with resectable colorectal liver metastasesQ37530660
Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastasesQ37621305
Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liverQ37625605
Surgical management of hepatic metastases of colorectal originQ37630485
Systemic chemotherapy and its implications for resection of colorectal liver metastasisQ37644758
Pre-operative chemotherapy for colorectal cancer liver metastases: an update of recent clinical trials.Q37718030
Role of adjuvant therapy after resection of colorectal cancer liver metastasesQ37724550
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise?Q37768890
Evolution of neoadjuvant therapy for extended hepatic metastases--have we reached our (non-resectable) limit?Q37821841
The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support?Q37831218
Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancerQ37907117
Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect?Q39754325
Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?Q42841253
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.Q44486167
Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.Q45924115
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
neoadjuvant chemotherapyQ108855558
P304page(s)e86543
P577publication date2014-01-21
P1433published inPLOS OneQ564954
P1476titleEffect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
P478volume9

Reverse relations

cites work (P2860)
Q37735615Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer
Q34207776Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?
Q38836982Influence of neoadjuvant chemotherapy on resection of primary colorectal liver metastases: A propensity score analysis
Q38256165Liver-directed therapies in metastatic colorectal cancer
Q38386343Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers
Q90581021Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
Q47769444Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial
Q92727057Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
Q36344123Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases
Q90627128SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)
Q35988684The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
Q38528849Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?

Search more.